TLDR Finasteride shows promise for preventing prostate cancer, but more research is needed.
The document discussed the potential of finasteride as a chemoprevention agent for prostate cancer, which had a high prevalence and significant morbidity and mortality. Finasteride met most criteria for chemoprevention, but further research was needed to clarify issues such as the increase in Gleason score, health savings, side effects on sexuality, impact on patient survival, and identifying the ideal target population before it could be recommended for practical use.
11 citations
,
February 2004 in “Clinical and Experimental Ophthalmology” Taking Propecia might lead to the development of cataracts.
June 2024 in “Georgetown medical review” Finasteride treats hair loss but may cause low libido, erectile issues, and depression.
June 2017 in “Reactions Weekly” Finasteride (Propecia) may cause depression and suicidal thoughts; stop use and inform a healthcare professional if symptoms develop.
3 citations
,
June 2004 in “Annales De Dermatologie Et De Venereologie” Four new cases of gynecomastia (male breast enlargement) linked to finasteride (Propecia) have been found.
2 citations
,
January 2003 in “Journal of Clinical Dermatology” 1 mg finasteride can cause reversible painful breast enlargement in men.
April 2012 in “Reactions Weekly” Finasteride may cause more sexual side effects than previously thought.
